Dovremmo continuare a utilizzare le benzodiazepine nella pratica clinica?

Translated title of the contribution: Should we continue to use benzodiazepines in clinical practice?

Gaia Sampogna, Valeria Del Vecchio, Mario Luciano, Corrado De Rosa, Umberto Albert, Bernardo Dell'Osso, Andrea Fiorillo

Research output: Contribution to journalArticlepeer-review

Abstract

The discovery of benzodiazepines has represented a milestone in the history of pharmacological treatments and in relation to the management of anxiety, sleep and other psychiatric disorders. After several decades, these agents still represent one of the largest and most widely prescribed groups of medications, not only in the psychiatric clinical practice, but also in the whole medical field. Over the last decade, however, multiple concerns have been raised on the risks related to the prescription of benzodiazepines, for their addictive potential and for cognitive side-effects. Therefore, benzodiazepines are today considered as a double-edge sword, which should be carefully handled and preferentially prescribed by specialists (or at least under their supervision), after an adequate training. Unfortunately, this is not the case in many situations, and the need to improve training on benzodiazepines management has been recently emphasized.

Translated title of the contributionShould we continue to use benzodiazepines in clinical practice?
Original languageItalian
Pages (from-to)243-245
Number of pages3
JournalRecenti Progressi in Medicina
Volume106
Issue number6
DOIs
Publication statusPublished - Jun 1 2015

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Should we continue to use benzodiazepines in clinical practice?'. Together they form a unique fingerprint.

Cite this